设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
构建外科药师的知识体系——外科药学(Surgical Pharmacy)
作者:伍俊妍1  张梅1  王若伦2  魏理3  黎小妍4  曾英彤5  陈吉生6  季波7  吴红卫6  王景浩8  王勇9  郑志华9 
单位:1. 中山大学孙逸仙纪念医院, 广东 广州 510120;
2. 广州医科大学附属第二医院, 广东 广州 510260;
3. 广州医科大学附属第一医院, 广东 广州 510120;
4. 中山大学附属第六医院, 广东 广州 510655;
5. 广东省人民医院(广东省医学科学院), 广东 广州 510080;
6.
关键词:外科药师 外科药学 围手术期 知识体系 
中图分类号:R95
文献标志码:
出版年,卷(期):页码:2021,31(1):1-8,
收稿日期:2020-11-30
摘要:
围手术期用药的管理已成为临床药师重要的日常工作,目前已有部分医院设立外科药师。随着外科药师队伍的逐步壮大,如何针对围手术期用药特点,规范外科药师培训成为当务之急。然而,当前尚未形成一套系统的、完整的知识体系。外科围手术期由于其独特的特点,药学所面对的问题不同于其它疾病治疗,在知识体系方面足以构建为学科,我们称之为“外科药学(surgical pharmacy)”。本文创新性提出外科药学概念,通过搭建围手术期生理病理特征、外科药师的工作模式和流程、围手术期药物治疗、围手术期的药物管理等四个方面的知识版块,其中围手术期药物治疗包括抗感染、抗血栓、镇痛、营养、血糖、血压、液体管理、糖皮质激素的应用、术后恶心呕吐、特殊人群用药等,构建外科药师的知识体系——外科药学,为外科药师培训及工作规范化、专业化开展提供支撑。
The management of perioperative medication has become an important daily work for clinical pharmacists. At present,some hospitals have established the position of surgical pharmacist. As the number of surgical pharmacists increasing,the training of surgical pharmacists according to the characteristics of perioperative medication will become top priority. However,the body of knowledge for surgical pharmacists has not yet been established. During the perioperative period,due to its unique characteristics,the problems presented in pharmacy are different from the treatment of other diseases. In terms of knowledge system,it is enough to be constructed as a subject,which is called surgical pharmacy. In this paper,the concept of surgical pharmacy is put forward creatively. And the body of knowledge for surgical pharmacists,namely surgical pharmacy,is constructed from four aspects:perioperative pathophysiology,work pattern and work flow for surgical pharmacists,perioperative medication therapy, including anti-infection, anti-thrombosis, analgesia, nutrition, blood glucose, blood pressure and liquid management, the use of glucocorticoids, postoperative nausea and vomiting, and medication in special populations, and perioperative drug management,for the training of surgical pharmacists as well as the standardization and specialization of their work.
基金项目:
作者简介:
伍俊妍,主任药师,研究方向:药事管理,临床药学
通讯作者:郑志华,主任药师,研究方向:药事管理、医院药学和药学服务,E-mail:snownotrace@126.com
参考文献:
[1] 广东省药学会.临床药师术后疼痛管理指引[J].今日药学,2019,29(4):217-227.
[2] 广东省药学会.肠内营养临床药学共识(第二版)[J].今日药学,2017,27(6):361-371.
[3] 广东省药学会.围手术期血糖管理医-药专家共识[J].今日药学,2018,28(2):73-83.
[4] 广东省药学会.围手术期血压管理医-药专家共识[J].今日药学,2019,29(5):289-303.
[5] 广东省药学会.加速康复外科围手术期药物治疗管理医药专家共识[J].今日药学,2020,30(6):361-371.
[6] 赵文霞,伍俊妍,郑志华.外科药师参与骨科住院患者的药学实践[J].今日药学,2019,29(9):406-409.
[7] 卢钧雄,刘瑜,王若伦.临床药师在肝胆外科术后急性疼痛管理中的作用及工作实践[J].中国医院药学杂志,2019,39(20):2099-2102,2106.
[8] 郑志华,伍俊妍,曾英彤,等.推动"外科药师"的建立[J].今日药学,2020,30(4):259-260,271.
[9] American Society of Health-System Pharmacists. ASHP guidelines on perioperative pharmacy services[J]. Am J Health Syst Pharm,2019,76(12):903-820.
[10] Zheng Z,Wu J,Zeng Y,et al. Creating the position of surgical pharmacist in China[J]. Eur J Hosp Pharm,2020,27(6):e99.
[11] 谭基明.外科病理生理学[M]. 第2版.北京:人民卫生出版社,2009.
[12] 石汉平,詹文华.围手术期病理生理与临床[M]. 北京:人民卫生出版社,2010.
[13] 陈孝平,汪建平. 外科学[M]. 第8版.北京:人民卫生出版社,2013.
[14] Pellegrino A N,Martin M T,Tilton J J,et al. Medication therapy management services:definitions and outcomes[J]. Drugs,2009,69(4):393-406.
[15] Ljungqvist O,Scott M,Fearon K C. Enhanced Recovery After Surgery:A Review[J]. JAMA,2017,152(3):292-298.
[16] Lovely J K,Hyland S J,Smith A N,et al.Clinical pharmacist perspectives for optimizing pharmacotherapy within Enhanced Recovery After Surgery(ERAS)programs[J]. Int J Surg,2019,63:58-62.
[17] Bansal N,Morris J. Pharmacist involvement to improve patient outcomes in lower gastrointestinal surgery:a prospective before and after study[J]. Int J Clin Pharm,2019,41(5):1220-1226.
[18] Bicket M C,Brat G A,Hutfless S,et al. Optimizing opioid prescribing and pain treatment for surgery:Review and conceptual framework[J]. Am J Health Syst Pharm,2019,76(18):1403-1412.
[19] Bland C M,Quidley A M,Love B L,et al. Long-term pharmacotherapy considerations in the bariatric surgery patient[J]. Am J Health Syst Pharm,2016,73(16):1230-1242.
[20] Mueck K M,Kao L S. Patients at High-Risk for Surgical Site Infection[J]. Surg Infect,2017,18(4):440-446.
[21] 国家卫生计生委办公厅,国家中医药管理局办公室,解放军总后勤部卫生部药品器材局.抗菌药物临床应用指导原则[Z/OL].[2015-07-24].http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=c18e1014de6c45ed9f6f9d592b43db42&wYNOrhhjiR4y=1611019072110
[22] 刘凤林,张太平.中国普通外科围手术期血栓预防与管理指南[J].中国实用外科杂志,2016,36(5):469-474.
[23] Hornor M A,Duane T M,Ehlers A P,et al.American College of Surgeons' Guidelines for the Perioperative Management of Antithrombotic Medication[J]. J Am Coll Surg,2018,227(5):521-536.
[24] Argoff C E. Recent management advances in acute postoperative pain[J]. Pain Pract,2014,14(5):477-487.
[25] Nimmo S M,Foo I T H,Paterson H M. Enhanced recovery after surgery:Pain management[J]. J Surg Oncol,2017,116(5):583-591.
[26] Smiley D D,Umpierrez G E. Perioperative glucose control in the diabetic or nondiabetic patient[J]. South Med J,2006,99(6):580-589.
[27] Nordzij P G,Boersma E,Schreiner F,et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac,nonvascular surgery[J].Eur J Endocfinol,2007,156(1):137-142.
[28] Van Cauwenberge I,Philips J C,Seheen A J,et al.Anaesthetic risk related to cardiac autonomic neuropathy in diabetic patients[J]. Rev Med Liege,2008,63:488-493.
[29] Frisch A,Chandra P,Smiley D,et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery[J]. Diabetes Care,2010,33(8):1783-1788.
[30] Kwon S,Thompson R,Dellinger P,et al. Importance of perioperative glycemic control in general surgery:a report from the Surgical Care and Outcomes Assessment Program[J]. Ann Surg,2013,257(1):8-14.
[31] Vilar-Compte D,Alvarez de Iturbe I,Martín-Onraet A,et al. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy[J]. Am J Infect Control,2008,36(3):192-198.
[32] Goldberg M E,Larijani G E. Perioperative hypertension[J]. Pharmacotherapy,1998,18(5):911-914.
[33] Saugel B,Kouz K,Hoppe P,et al. Predicting hypotension in perioperative and intensive care medicine[J]. Best Pract Res Clin Anaesthesiol,2019,33(2):189-197.
[34] Aroke E N,Hicks T L. Pharmacogenetics of Postoperative Nausea and Vomiting[J]. J Perianesth Nurs,2019,34(6):1088-1105.
[35] Horn C C,Wallisch W J,Homanics G E,et al. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting[J]. Eur J Pharmacol,2014,722:55-66.
[36] Gan T J,Belani K G,Bergese S,et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting[J]. Anesth Analg,2020,131(2):411-448.
[37] 王巧萍,李景,王晓辉.术后恶心呕吐的危险因素与防治的研究进展[J].麻醉安全与质控,2019,3(4):240-244.
[38] Altemeyer K H,Kraus G B. Die perioperative Infusionstherapie im Kindesalter[Perioperative infusion therapy in children] [J]. Anaesthesist,1990,39(3):135-143.
[39] Abdallah F W,Morgan P J,Cil T,et al. Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection[J]. Anesthesiology,2014,120(3):703-713.
[40] Takagi K,Yoshida R,Yagi T,et al. Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy:A randomized controlled trial[J]. Clin Nutr,2019,38(1):174-181.
[41] Azhar R A,Bochner B,Catto J,et al. Enhanced Recovery after Urological Surgery:A Contemporary Systematic Review of Outcomes,Key Elements,and Research Needs[J]. Eur Urol,2016,70(1):176-187.
[42] Gan T J. Poorly controlled postoperative pain:prevalence,consequences,and prevention[J]. J Pain Res,2017,10:2287-2298.
[43] Zhao S,Chen F,Feng A,et al. Risk Factors and Prevention Strategies for Postoperative Opioid Abuse[J]. Pain Res Manag,2019,10:7490801.
[44] 广东省药学会.预防性使用质子泵抑制剂及处方精简专家指导意见[J].今日药学,2019,29(8):505-514.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 187156 位访问者